In summary, nine gene signatures (CYFIP2, HOXB5, EGFR, FOXN3, PTPN3, CDC20, MARCKSL1, FAS, and PTCH1) may play central roles in the initiation and progression of BCC, which provides deeper insights into BCC management. The gene discussed is PTPN3; the disease is skin basal cell carcinoma.